Newly introduced. Research grade Non-anticoagulant heparin.
- Produced by cleaving heparin primarily at its antithrombin binding sites
- Reserves heparin’s anti-viral and anti-inflammatory activities while greatly reduced its anticoagulant activity
- Can be used in high dose anti-viral and anti-inflammatory research without causing bleeding
- Reports indicate it binds the spike protein of SARS-CoV-2
13th Oct 2020